/Latest News

Webinar on Demand: 2D vs 3D Cell Culture Models and Advanced Techniques

There is no single “one size fits all” cell-based assay however 3D cell cultures have been shown to be more physiologically relevant in oncology, immune oncology and other fields.

By |2020-06-24T14:17:18+00:00June 24th, 2020|Categories: Latest News, Video|Tags: , , , |0 Comments

Webinar on Demand: A Modern Approach to Traditional Virology Research

During this webinar, Dr. Suzanne Riches highlights a variety of approaches for conducting virology assays in a high-throughput format.

By |2020-06-23T14:31:54+00:00May 12th, 2020|Categories: Latest News, Video|Tags: , , , |0 Comments

The Cellaca MX High-throughput Cell Counter from Nexcelom Bioscience has been nominated for a Scientists’ Choice Award

We are delighted to announce that, thanks to our loyal customers, the Cellaca™ MX High-throughput Cell Counter has been nominated in the Life Sciences category.

By |2020-04-22T16:59:58+00:00April 21st, 2020|Categories: Company News, Latest News|Tags: , |0 Comments

Is your trypan blue rupturing dead or dying immune cells leading to an over-estimation of cell viability?

It is important for biologists to select the most accurate cell counting method that is fit-for-purpose, especially for cellular therapy products such as CAR T, where cell number and viability significantly affect treatment efficacy.

Is Your Lab Using High-throughput Image Cytometry to Expedite Viral Assay Development and Research of SARS-CoV-2?

Fast track vaccine development process by conducting assays in 96- or 384-well plates based on enumeration of foci, plaque or single infected cells.

Fight Against Coronavirus: Nexcelom China Team Provides Assay Development Support to Scientists

Nexcelom's China team works with scientists in State Key Laboratory of Respiratory Diseases in China, for the screening of antiviral agents against SARS-CoV-2 virus, the cause of COVID-19 (Corona Virus).

By |2020-05-21T14:16:14+00:00March 3rd, 2020|Categories: Celigo Application News, Latest News|Tags: , , , |0 Comments

Webinar on Demand: Role of Aneuploidy and DNA Damage in the Onset of Human Solid Tumors – Lessons from Mouse Models of Chromosome Losses

Available on demand. During this webinar, Dr. Thomas will share his research in cancer biology related to DNA damage in the onset of solid tumors.

Webinar On-Demand: Cell Therapy Development for Solid Tumors

In this webinar, we highlight a variety of assays to support the development of cell therapies for solid tumors.